From simple neck pain to the diagnosis of Langerhans cell histiocytosis in the thyroid gland
Sažetak
Introduction. Langerhans cell histiocytosis (LCH), as a hematopoietic neoplasm, is a clonal proliferation of Langerhans dendritic cells. A comprehensive clinical examination is sometimes crucial for detecting rare adult diseases, such as LCH with concomitant autoimmune thyroid disease. Case report. A 43-year-old female patient first presented for an endocrinology consultation due to front neck pain and swelling accompanied by fatigue and malaise. The physical examination revealed an enlarged right thyroid gland lobe of extremely firm consistency that was painfully tender on palpation. Echosonographic findings confirmed that the right thyroid gland lobe was enlarged and was not clearly demarcated from the surrounding tissue while exhibiting pronounced parenchyma inhomogeneity characterized by reduced echogenicity of the anterior aspect and pronounced hypoechoicity of the posterior aspect, permeated with fibrous bands and calcifications. The structure of the left thyroid lobe was pseudonodular, with the characteristics of a chronic inflammatory process. Biohumoral findings indicated chronic autoimmune thyroiditis and primary hypothyroidism. Medical history, clinical findings, and personal and family predisposition to malignancy confirmed the need for accelerated additional diagnosis. Fine-needle aspiration biopsy was indicative of atypia of undetermined significance involving Hurthle cells, nuclear overlaps, anisocytosis, anisonucleosis, and the presence of nuclear incisions. Analyses performed after thyroidectomy pointed to the fibrous form of chronic thyroiditis, with suspected monoclonal proliferation of histiocytic and/or lymphoid cells. Immunohistochemical findings confirmed Hashimoto’s thyroiditis and LCH. As the postoperative course was favorable, the patient was prescribed L-thyroxine replacement therapy, along with continuous and systematic monitoring for histiocytosis. Conclusion. Histiocytosis should be suspected more often, given the high incidence of autoimmune thyroid disease in adulthood. A timely LCH diagnosis largely determines the outcome.
Reference
1. Dursun A, Pala EE, Ugurlu L, Aydin C. Primary Langerhans cell histiocytosis in thyroid. Acta Endocrinol 2020; 16(4): 501–4.
2. Patten DK, Wani Z, Tolley N. Solitary Langerhans histiocytosis of the thyroid gland: A case report and literature review. Head Neck Pathol 2012; 6(2): 279−89.
3. Milenković B, Bogdanović A, Cvok T, Mitić J, Stojšić J, Dudvarski-Ilić A. Pulmonary histiocytosis. Med Pregl 2013; 66(Suppl. 1): 101–5.
4. Nezelof C, Basset F, Rousseau MF. Histiocytosis X histogenetic arguments for a Langerhans cell origin. Biomedicine 1973; 18(5): 365−71.
5. Ceyran AB, Senol S, Bayraktar B, Ozkanli S, Cinel ZL, Aydin A. Langerhans cell histiocytosis of the thyroid with multiple cervical lymph node involvement accompanying metastatic thyroid papillary carcinoma. Case Rep Pathol 2014; 184237.
6. Haroche J, Cohen-Aubart F, Emile JF, Arnaud L, Maksud P, Charlotte F, et al. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood 2013; 121(9): 1495–500.
7. A Al Hamad M, Albisher HM, Saeed WR, Almumtin AT, Allabbad FM, A Shawarby M. BRAF gene mutations in synchronous papillary thyroid carcinoma and Langerhans cell histiocytosis co-existing in the thyroid gland: a case report and literature review. BMC Cancer 2019; 19(1): 170.
8. Behrens RJ, Levi AW, Westra WH, Dutta D, Cooper DS. Langerhans cell histiocytosis of the thyroid: A report of two cases and review of the literature. Thyroid 2001; 11(7): 697−705.
9. Braiteh F, Kurzrock R. Case 1. Langerhans cell histiocytosis of the thyroid. J Clin Oncol 2006; 24(3): 522−3.
10. Hung CS, Yeh YC, Chen JC, Jung SM, Hung IJ, Lo FS. Isolated Langerhans cell histiocytosis of the thyroid in a female infant. Eur J Pediatr 2007; 166(11): 1151−3.
11. Elliott DD, Sellin R, Egger JF, Medeiros LJ. Langerhans cell histiocytosis presenting as a thyroid gland mass. Ann Diagn Pathol 2005; 9(5): 267−74.
12. Goldstein N, Layfield LJ. Thyromegaly secondary to simultaneous papillary carcinoma and histiocytosis X. Report of a case and review of the literature. Acta Cytol 1991; 35(4): 422−6.
13. Yağci B, Kandemir N, Yazici N, Yalçin B, Varan A, Akyüz C, et al. Thyroid involvement in Langerhans cell histiocytosis: A report of two cases and review of the literature. Eur J Pediatr 2007; 166(9): 901−4.
14. Jamaati HR, Shadmehr MB, Saidi B, Khosravi A, Arab M, Mohammadi F. Langerhans cell histiocytosis of the lung and thyroid, co-existing with papillary thyroid cancer. Endocr Pathol 2009; 20(2): 133−6.
15. Abla O, Egeler RM, Weitzman S. Langerhans cell histiocytosis: Current concepts and treatments. Cancer Treat Rev 2010; 36(4): 354−9.
16. Satter EK, High WA. Langerhans cell histiocytosis: A review of the current recommendations of the Histiocyte Society. Pediatr Dermatol 2008; 25(3): 291−5.
17. Haupt R, Minkov M, Astigarraga I, Schäfer E, Nanduri V, Jubran R, et al. Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer 2013; 60(2): 175−84.
18. Tazi A. Adult pulmonary Langerhans’ cell histiocytosis. Eur Respir J 2006; 27(6): 1272−85.
19. Bermingham N, Townley D, Fenton S, Keohane C. Ocular Langerhans cell histiocytosis. Eye 2007; 21(8): 1127−8.
20. Das JK, Soibam R, Tiwary BK, Magdalene D, Paul SB, Bhuyan C. Orbital manifestations of Langerhans cell histiocytosis: A report of three cases. J Ophthalmol 2009; 2(3): 137−40.